DD-04 PENAO: A POTENT MITOCHONDRIAL TARGETED INHIBITOR FOR GLIOBLASTOMA

PENAO (4-(N-(S-penicillaminylacetyl)amino)phenylarsonous acid) is a promising new treatment for glioblastoma patients and is currently in Phase-I clinical trial testing. PENAO selectively targets cancer-specific mitochondrial metabolism by binding to the inner-mitochondrial membrane protein adenine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chung, Sylvia, Decollogne, Stephanie, Luk, Peter, Shen, Han, Ha, Wendy, Day, Bryan, Stringer, Brett, Hogg, Philip, Dilda, Pierre, McDonald, Kerrie
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218034/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou246.4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados